卵巢癌的靶向治疗.pptVIP

/oncology Beyond Chemotherapy Saturday, February 7, 2009 1:00 PM - 2:30 PM San Antonio Marriott Riverwalk Ballroom LevelSalon ABC San Antonio, Texas Beyond Chemotherapy: Current and Future Molecular-Targeted Therapy in Ovarian Cancer This program is supported by an educational grant from Michael V. Seiden, MD, PhDPresident and Chief Executive OfficerFox Chase Cancer CenterPhiladelphia, Pennsylvania The Need for Molecular-Targeted Therapy GOG 111: Standard of Care Study design Cisplatin 135 mg2 IV over 24 hours + Paclitaxel 75 mg/m2 x 6 cycles (n = 184) Cisplatin 75 mg/m2 x 6 cycles +